English
Español
Français
Português
Русский
العربية
MSF Science Portal
My saved items
Home
English
Español
Français
Português
Русский
عَرَبِيّ
About MSF
About MSF Science Portal
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
My saved items
Search and access MSF research content
Using quotation marks can improve results for journals and authors
Search
View All
Conference Material > Video
24-week regimens for treatment of rifampicin-resistant tuberculosis: four-arm randomised trial
Berry C,
Motta I,
Kazounis E,
Fielding K,
Dodd M,
Nyang'wa BT,
Moodliar R
Save
Cite
Share
Linked Items
Save
Cite
Share
Video
Countries
Belarus
South Africa
Uzbekistan
Subject Area
antibiotic resistance
tuberculosis
antimicrobial resistance
Collections
TB-PRACTECAL Trial—Evidence for a shorter, safer, more effective treatment for drug-resistant tuberculosis
DOI
10.57740/atfr-ws57
Published Date
07-Jun-2022
Languages
English
Conference
MSF Scientific Days International 2022
Linked Items
Conference Material > Abstract
24-week regimens for treatment of rifampicin-resistant tuberculosis: four-arm randomised trial
11-May-2022
Conference Material > Slide Presentation
24-week regimens for treatment of rifampicin-resistant tuberculosis: four-arm randomised trial
11-May-2022